BRIC Market Report Suite for Immunology Drugs 2017 - ResearchAndMarkets.com

DUBLIN--()--The "BRIC Market Report Suite for Immunology Drugs 2017 - MedSuite" report has been added to ResearchAndMarkets.com's offering.

Besides the typical market data found above you will be able to discover how these diseases have been trending over time, their epidemiology, drivers and limiters of these markets, Porter's Five Forces analysis, clinical trials, a pipeline of products coming out soon, mergers and acquisitions, company profiles and SWOT analyses.

Companies Mentioned

  • AbbVie Inc.
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Takeda Pharmaceuticals
  • UCB S.A.

Key Topics Covered:

Disease Overview

  • Rheumatoid Arthritis
  • Crohn's Disease
  • Ankylosing Spondylitis
  • Psoriasis
  • Ulcerative Colitis

Product Assessment

  • Clinical Trials Overview
  • Pipeline Analysis
  • Promising new drugs for Ankylosing Spondylitis in the pipeline
  • Promising new drugs for Crohn's Disease in the pipeline
  • Promising new drugs for Psoriasis in the pipeline
  • Promising new drugs for Rheumatoid Arthritis in the pipeline

Key Marketed Products Portfoilo

  • Orencia (abatacept)
  • Humira (adalimumab)
  • Cimzia (certolizumab)
  • Enbrel (etanercept)
  • Benepali (etanercept)
  • Simponi (golimumab)
  • Remicade (infliximab) + Remsima/Inflectra (infliximab)
  • Inflectra (infliximab)
  • Flixabi (infliximab)
  • Rituxan (rituximab)
  • Actemra/RoActemra (toclizumab)
  • XELJANZ (tofacitnib)
  • Kineret (anakinra)
  • Stelara (ustekinumab)
  • Entyvio (vedolizumab)
  • Tysabri (natalizumab)
  • Cosentyx (secukinumab)
  • Taltz (ixekizumab)

Drug Cost Analysis

BRIC Immunology Market Overview

BRIC Immunology Market - By Diseases

BRIC Immunology Market - By Treatments

BRIC Immunology Biologics Segment Analysis - By Drugs

BRIC Immunology Biologics Segment Analysis - By Mechanism Of Action (MOA)

Country Profiles

Competitive Landscape

Company Profiles

Future Outlook of the Market

Abbreviations

For more information about this report visit https://www.researchandmarkets.com/research/3znmnm/bric_market?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs